624 related articles for article (PubMed ID: 10508512)
1. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.
Song WJ; Sullivan MG; Legare RD; Hutchings S; Tan X; Kufrin D; Ratajczak J; Resende IC; Haworth C; Hock R; Loh M; Felix C; Roy DC; Busque L; Kurnit D; Willman C; Gewirtz AM; Speck NA; Bushweller JH; Li FP; Gardiner K; Poncz M; Maris JM; Gilliland DG
Nat Genet; 1999 Oct; 23(2):166-75. PubMed ID: 10508512
[TBL] [Abstract][Full Text] [Related]
2. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
[TBL] [Abstract][Full Text] [Related]
3. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
[TBL] [Abstract][Full Text] [Related]
4. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.
Michaud J; Wu F; Osato M; Cottles GM; Yanagida M; Asou N; Shigesada K; Ito Y; Benson KF; Raskind WH; Rossier C; Antonarakis SE; Israels S; McNicol A; Weiss H; Horwitz M; Scott HS
Blood; 2002 Feb; 99(4):1364-72. PubMed ID: 11830488
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.
Béri-Dexheimer M; Latger-Cannard V; Philippe C; Bonnet C; Chambon P; Roth V; Grégoire MJ; Bordigoni P; Lecompte T; Leheup B; Jonveaux P
Eur J Hum Genet; 2008 Aug; 16(8):1014-8. PubMed ID: 18478040
[TBL] [Abstract][Full Text] [Related]
6. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
[TBL] [Abstract][Full Text] [Related]
7. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
8. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
[TBL] [Abstract][Full Text] [Related]
9. A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.
Buijs A; Poddighe P; van Wijk R; van Solinge W; Borst E; Verdonck L; Hagenbeek A; Pearson P; Lokhorst H
Blood; 2001 Nov; 98(9):2856-8. PubMed ID: 11675361
[TBL] [Abstract][Full Text] [Related]
10. AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia.
Barton K; Nucifora G
Bioessays; 2000 Mar; 22(3):214-8. PubMed ID: 10684580
[TBL] [Abstract][Full Text] [Related]
11. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
[TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.
Yamashita N; Osato M; Huang L; Yanagida M; Kogan SC; Iwasaki M; Nakamura T; Shigesada K; Asou N; Ito Y
Br J Haematol; 2005 Nov; 131(4):495-507. PubMed ID: 16281942
[TBL] [Abstract][Full Text] [Related]
13. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
14. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis.
Ruiz-Perez VL; Ide SE; Strom TM; Lorenz B; Wilson D; Woods K; King L; Francomano C; Freisinger P; Spranger S; Marino B; Dallapiccola B; Wright M; Meitinger T; Polymeropoulos MH; Goodship J
Nat Genet; 2000 Mar; 24(3):283-6. PubMed ID: 10700184
[TBL] [Abstract][Full Text] [Related]
15. A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia.
Walker LC; Stevens J; Campbell H; Corbett R; Spearing R; Heaton D; Macdonald DH; Morris CM; Ganly P
Br J Haematol; 2002 Jun; 117(4):878-81. PubMed ID: 12060124
[TBL] [Abstract][Full Text] [Related]
16. Recurrent CDC25C mutations drive malignant transformation in FPD/AML.
Yoshimi A; Toya T; Kawazu M; Ueno T; Tsukamoto A; Iizuka H; Nakagawa M; Nannya Y; Arai S; Harada H; Usuki K; Hayashi Y; Ito E; Kirito K; Nakajima H; Ichikawa M; Mano H; Kurokawa M
Nat Commun; 2014 Aug; 5():4770. PubMed ID: 25159113
[TBL] [Abstract][Full Text] [Related]
17. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
18. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.
Ganly P; Walker LC; Morris CM
Leuk Lymphoma; 2004 Jan; 45(1):1-10. PubMed ID: 15061191
[TBL] [Abstract][Full Text] [Related]
19. Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia.
Steensma DP; Gibbons RJ; Mesa RA; Tefferi A; Higgs DR
Eur J Haematol; 2005 Jan; 74(1):47-53. PubMed ID: 15613106
[TBL] [Abstract][Full Text] [Related]
20. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
